Ken Griffin Biocept Inc Put Options Transaction History

Citadel Advisors LLC

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2023 May 15, 2023	SELL	$0.24 - $0.62 $24 - $62	-100 Reduced 50.0%	100 $0
Q4 2022 Feb 14, 2023	BUY	$0.47 - $0.89 $94 - $178	200 New	200 $0

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.